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Summary
Mast cell-associated mediators are generally classified into two groups: the preformed mediators,
which are stored in the cells' cytoplasmic granules and are released upon exocytosis, and the newly
synthesized mediators, which are not stored but are produced and secreted only afterappropriate
stimulation of the cell. We now report that tumor necrosis factor a (TNF-cr)/cachectin represents
a new type of mast cell-associated mediator, in that IgE-dependent mast cell activation results
in the rapid release ofpreformed stores of the cytokine followed by the synthesis and sustained
release of large quantities of newly formed TNF-a. We also demonstrate that challenge with
specific antigen induces higher levels ofTNF-a mRNA at skin sites sensitized with IgE in normal
mice or mast cell-reconstituted genetically mast cell-deficient WBB6Fi-W/ W° mice than at
identically treated sites in WBB6FvW/W° mice that are devoid of mast cells. These findings
identify mast cells as a biologically significant source of TNF-a/cachectin during IgE-dependent
responses and define a mechanism whereby stimulation of mast cells via the FCERI can account
for both the rapid and sustained release of this cytokine.
T
he biologically active mediators elaborated by mast cells
are traditionally assigned to two groups (1, 2). One class
of mediators, which includes histamine, serotonin, heparin,
and other proteoglycans, and certain proteases, are stored in
the cells' cytoplasmic granules. While extracellular release of
these products is an energy-dependent process, expression of
the bioactivities requires only exocytosis of cytoplasmic
granules containing the preformed mediators. By contrast,
another class of mediators, which includes products of the
cyclooxygenase or lipoxygenase pathways ofarachidonic acid
metabolism and platelet activating factor, are not stored by
mast cells, but are synthesized and released upon activation
of the cells. However, several recent findings indicate that
it may not be appropriate to classify all mast cell-associated
mediators as either preformed or newly synthesized. It is now
clear that in vitro derived mouse mast cells stimulated via
the FCERI or by other mechanisms can express increased
levels ofmRNA for a wide rangeo£multifunctional cytokines
and, in some instances, release the products (3-6). In the case
of one of these cytokines, TNF-a/cachectin, both in vitro
derived and freshly purified mouse mast cells also constitu-
tively store significant amounts of the bioactivity (6). The
presence of preformed stores of TNF-a in mast cells is of
interest, in that other cell types that produce this cytokine,
such as macrophages (7-9), T cells (10), and B cells (11), contain
little or no detectable TNF-cr unless they are appropriately
stimulated. We recently showed that stimulation of mouse
mast cells via the FCERI resulted in both the release of
TNF-a bioactivity and also increased levels ofTNF-a mRNA
(6). However, the extent to which the TNF-a bioactivity
released by activated mast cells reflected the secretion of
preformed as opposed to newly synthesized cytokine was not
determined.
In the present study, we demonstrate that the TNF-
c t/cachectin released by mouse mast cells upon IgE-dependent
stimulation is derived from two distinct pools, a preformed
pool, which accounts for most of the product released during
the first 10 min after stimulation, and a newly synthesized
pool, which accounts for the later, sustained release of the
cytokine. These findings indicate that TNF-a/cachectin
represents a new type of mast cell-associated mediator, which
expresses bioactivity through the effects of both preformed
and newly synthesized product.
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Cells.
￿
The derivation of the 11,3-independent cloned mast cell
line CLMC/C57.1 hasbeen reported (12) . Primarycultures ofIL3-
dependent, bone marrow-derived cultured mast cells (BMCMC)'
and purified peritoneal mast cells (PMC) were prepared from re-
tired breeder BALB/c mice (6). BMCMC (>95% mast cells by
staining with neutral red) were used 4-5 wk after the initiation
of culture (6). Purified PMC contained >98% mast cells according
to neutral red staining (6). The L929 cell line was obtained and
maintained as reported (6, 12). For FcERI-dependent activation,
mast cells were sensitized with a monoclonal (mc) IgE anti-
dinitrophenol (DNP) antibody (13) for3h(6). The CLMC/C57.1
cells and BMCMC were then stimulated with DNP_~o_4o HSA (50
ng/ml;Sigma Chemical Co., St. Louis, MO) (5, 6), whereas PMC
were challenged with a rat me anti-mouse IgE (150 ng/ml final
concentration) (6). In experiments measuring the release of pre-
formed, as opposed to newly synthesized TNF-a, the transcrip-
tion inhibitor actinomycin D (act D, 10 t~g/ml; Sigma Chemical
Co.) was added to the cultures 5-10 min before activation of the
cells with antigen or anti-IgE.
Measurement of TNFa Secretion.
￿
TNF-a bioactivity in mast
cell supernatants wasdetected using an MTT18-h cytotoxicity assay
with L929 target cells (6). Thespecificity of the cytotoxicactivity
wasdetermined by neutralization with amonospecific rabbit anti-
TNF-a antisera (6), andrecombinant murine TNF-a (Genzyme,
Boston, MA)standards wereincluded in each assay. Statistical anal-
ysis of the data was performed using a two-tailed Students t test.
Serotonin Release Assay.
￿
To evaluate the release of a classical
preformed mediator, we monitored the kinetics of release of the
cytoplasmic granule-associated mediator serotonin(5-hydroxytrypta-
mine; 5-HT) (14) . Briefly, me IgE anti-DNP and 5-[1,2?H](N)-
hydroxytryptamine creatinine sulfate (New England Nuclear,
Boston, MA) (sp act, 25.2 Ci/mmol, 1 uCi/ml) were added to
the mast cells for 3 h, then thecells were washed and challenged
with antigen (CLMC/C57.1 andBMCMC) or me anti-IgE (PMC)
as noted above. Thepercent specific [311]5-HT release was calcu-
lated (14) usingtheformula: percent specific release = 100x [(cpm
stimulated release/cpm stimulated cells + supernatant) - (cpm
unstimulated release/cpm unstimulated cells + supernatants)].
Isolation ofRNA.
￿
RNAwas obtained from the cultured cells
as described(5,6) andfrom mouse skin specimens after homogeni-
zation in guanidinium isothiocyanate solution (5, 6) usinga tissue
homogenizer (Polytron, Kinematica GmbH Littau, Switzerland).
The homogenates were cleared by centrifugation for 30 min at
-16,000g, the cellular RNA was isolated (5, 6), and the mRNA
was purified by oligo d(T) cellulose chromatography (6).
Northern Blotting ofRNA.
￿
Briefly, theRNAwassize fraction-
ated on formaldehyde-agarose gels and transferred to nylon mem-
branes (Zeta-bind; Cuno Laboratories, Meriden, CT). The blots
were hybridized with "P-labeled specific cDNA probes, washed
at high stringency, and photographed (6). In some experiments,
the signals on the autoradiographs were quantitated by laser den-
sitometry, and theresults correctedforvariation in RNAloading,
as determined by reference to control (actin) cDNA probes.
Molecular Probes for Detection of Cytokine mRNA.
￿
The 1-kb
TNF-ci cDNA probe(15), an EcoRIfragment from aplasmidgener-
ously provided by Dr. Michael Palladino (Genentech, Inc., South
1 Abbreviations used in this paper: act D, actinomycin D; BMCMC, bone
marrow-derived cultured mast cells; 5-HT, 5-hydroxytryptamine; LPR,
late phasereaction;mc, monoclonal;PCA, passivecutaneous anaphylaxis;
PMC, peritoneal mast cells.
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San Francisco, CA), was body labeled with [12p]dCTP using the
random hexamer priming method. A synthetic oligonucleotide
probe (sequence: 5'-GTCCCCCTTCTCCAGCTGGAAGACT
CCTCC-3') specific for exon 4 ofmurine TNF-a (16) was gener-
ously provided by Dr. Glen Andrews (Pfizer Pharmaceuticals,
Groton, CT) andwas 3' labeled with [32p]ATP using the terminal
deoxynucleotidyl transferree reaction. Both probes were used as
noted (6).
Determination of TNF-ci mRNA Half-Life.
￿
Briefly, 60-90 min
after immunologic activation ofthe mast cells, act D (10 wg/ml)
was added to the cell cultures to block nascent transcription, and
at varyingintervals thereafter, theresidual cellular mRNA wasex-
tracted from the cells and analyzed by Northern blotting. The
amount of specific mRNA was quantified by laser densitometry
(above) and the biologic half-life (t3/2) determined from the
graphed results.
Induction of Passive Cutaneous Anaphylaxis (PCA) Responses.
Briefly, we injected x+48 ng ofme IgEanti-DNP antibody in 20 Pl
ofHepes-buffered HBSS (Hepes-HBSS) intradermally into theears.
After 24 h, the mice were challenged intravenously with 100 ug
of DNP3o-ao-HSA (Sigma Chemical Co.) in 200 ul of Hepes-HBSS
containing 0.5% Evan's blue dye. The presence of PCA reactivity
was confirmed by measuring the ear swelling (A ear thickness)
and/or by assessing the extravasation of Evan's blue dye (17). At
45 minafterantigen challenge, earbiopsies were processedfor RNA
extraction and Northern analysis as noted above.
Local Cutaneous Mast Cell Reconstitution of W/W° Mice.
￿
The
chronic application of PMA to the skin of genetically mast
cell-deficient WBB6F,-W/W° mice induces the development of
largenumbers ofphenotypically normal dermal mast cellsthat are
competent to orchestrate PCA reactions (17). This effect is local-
ized to the PMA-treated site; mast cells do not develop at con-
tralateral sites treated with vehicle (acetone) alone (17). The mast
cellsthat develop at PMA-treated sitespersistfor at least8wk after
the PMA treatments are stopped and the local inflammatory re-
sponses have waned (our unpublished results) . For the experiments
reported here, we induced mast cell development in the ear skin
of W/W° mice by chronic application of PMA (5 wg/site in 5 A1
of acetone, three times per week for 6 wk); the contralateral ears
were treated on the same schedule with acetone alone (17). The
animals were then left untreatedforan additional 6-8wk,to permit
the local inflammatory reactions to subside.
Results and Discussion
Kinetics ofInduction of TNF-alCachectin mRNA in Mast
Cells Stimulated via the FCAL We first determined the ki-
netics of TNF-Q mRNA induction in CLMC/C57.1 mast
cells stimulated via the FcERI (Fig. ') .TNF-cat mRNA in-
creased to very high levels by 30-60 min after challenge, then
graduallywanedby 4-6 hafterstimulation. We showed that
the signals in these blots indeed represented TNF-ci mRNA
by probing similar blotswith an oligonucleotide probespecific
for exon 4 of TNF-cx (Fig. 1). Primary populations of IL3-
dependentBMCMCstimulated with IgEandspecific antigen
exhibited kinetics ofTNF-ca mRNA induction that were the
same as those observed with CLMC/C57.1 mast cells (data
not shown). The t1i2 of TNF-ca mRNA in either CLMC/
C57.1 cells or BMCMC was -35 min.
Kinetics ofRelease ofPreformedor Newly Synthesized TNF-
alCachectin by Mast Cells. To assess the contribution of
preformed as opposed to newly synthesized TNF-a/cachectinFigure 1 .
￿
Northern blot analysis of the kinetics of induction of TNF-
a/cachectin mRNA in mast cells stimulated via the FcERI. C1.MC/C57 . 1
cells were sensitized with me IgE anti-DNP antibody, washed, and then
challenged with DNP3o-4o-HSA . At the times shown, total cellular RNA
was extracted from the cells and processed for Northern blotting . The
upper panel is an autoradiograph of a Northern blot probed with a 32P_
labeled 1-kb TNF-a cDNA probe and aUV photograph prepared ofthe
ethidium bromide-stained RNA in the gel before blotting . The lower
panel is an autoradiograph of a Northern blot similar to that in upper
panel, but probed with a 32P-labeled 30-base synthetic oligonucleotide
probe specific for exon 4 of TNF-a .
to the cytokine bioactivity released upon IgE-dependent mast
cell stimulation, we activated the cells either in the presence
(+) or absence (-) of act D (Fig . 2) . Identically treated mast
cells that first had been permitted to incorporate [3H]5-HT
were also tested, to determine whether act D treatment
influenced release of the cytoplasmic granule-associated
preformed mediator 5-HT (Fig. 2) . In C1.MC/C57.1 mast
cells tested in the absence of act D (Fig . 2 a), release of
[3H]5-HT reached maximal levels within 10 min of antigen
challenge, whereas release ofTNF-a bioactivity did not achieve
maximal levels until 60 min after challenge . In the presence
of act D (Fig. 2 b), the C1.MC/C57.1 mast cells released
substantially less TNF-ci bioactivity, which reached maximal
levels by 10 min and actually declined thereafter (Fig. 2 b) .
Note that data for TNF-a release in Fig . 2, a and b areshown
on a log scale ; maximal levels of release of preformedTNF-a
(Fig. 2 b) represented only -10% of the maximal levels of
cytokine released by cells stimulated in the absence of actD
(Fig. 2 a) . Similar results were obtained withBMCMC and
purified PMC (Fig . 2 c) .
Taken together, these experiments show that in cloned mast
cells, primary cultures ofimmature IL-3-dependent mast cells,
and purified mature PMC, FcERI-dependent activation
results in the rapid release of preformed stores of TNF-
a/cachectin followed by the sustained release of substantially
greater amounts o£ newly formed cytokine. In contrast to
its dramatic effect on TNF-ci release, incubation with actD
had no discernable effect (p > 0.05 at all time intervals) on
IgE-dependent release of [ 3H]5-HT from any of the mast
cell populations (Fig. 2, a-c) . The latter results indicated that
the effect of actD on TNF-a release did not reflect an im-
pairment of mast cell exocytosis per se, but instead was due
to its ability to block the synthesis of TNF-a in response
to IgE-dependent stimulation of the cells.
Mast Cells Represent a Major Source of TNF-ci mRNA In
Viva To determine if mast cells represented a significant
source of TNF-ci during IgE-dependent immunological re-
sponses in vivo, we searched for TNF-amRNA in the skin
of normal (WBB6Ft-+/+) mice, genetically mast cell-
deficient WBB6Ft-W/W° mice, and mast cell-reconstituted
WIWI mice after sensitization of the cutaneous sites with
me IgE anti-DNP and intravenous challenge of the animals
24 h later with DNP-HSA (Fig. 3) . As reported previously
(17, 18), significant tissue swelling occurred in association
with 30-min PCA reactions in +/+ mice but not at identi-
Figure 2 .
￿
Kinetics ofrelease of pre-
formed and newly synthesized TNF-a/
cachectin from mast cells stimulated via
the FcERI. Mast cells were sensitized
with IgE and then challenged with
DNP3o.go-HSA in the presence (+) or
absence (-) of the transcription inhib-
itor actD at 10 hg/ml . In some experi-
ments, the cells were incubated with
[3H]5-HT (1 uCi/ml) during the IgE
sensitization period, to permit the cells
to incorporate [3H]5-HT into their cy-
toplasmic granules before washing and
challenge with specific antigen (see
Materials and Methods) . (a) Kinetics of
secretion of [3H]5-HT and TNF-a
from C1.MC/C57 .1 cells in the absence
of act D. (b) Kinetics of secretion of
[3H]5-HT and TNF-a from CI.MC/C57 . 1 cells in the presence of act D. (c) Effect of transcription inhibition with actD on the secretion of [3H]5-HT
and TNF-a from primary cultures ofmouseBMCMC and from purified freshly isolated mousePMC. Data for TNF-ci are mean ± SEM (n = 4/point) ;
data for [3H]5-HT are mean ± SEM (n = 2-4/point) . Values for TNF-a release in the absence of act D are significantly different (P < 0.01) than
values for the same cell types in the presence of act D at all intervals _>30 min after initiation of stimulation for C1.MC/C57 .1 cells and at 90 min
after initiation of stimulation for BMCMC and PMC.
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TNF-a/cachectin mRNA induction after specific immuno-
logic challenge of IgE-sensitized skin in mice is mast cell dependent . (a)
Leftpanel, IgE-dependent dermal inflammatory responses in IgE-sensitized
skin ofgenetically mast cell-deficient WBB6F,-W/Wv (WIWI) mice or
the congenic normal WBB6F1-+/+ (+/+) mice, as measured by ear-
swelling 30 min after intravenous antigen challenge. (Rightpanel) Relative
TNF-u mRNA levels 45 min after antigen challenge in biopsies of cuta-
neous reaction sites obtained from the WIW~ and +/+ mice shown in
the left panel, as determined by laser densitometric scanning of Northern
blot autoradiographs. The levels of actinmRNA in the biopsies wereused
as internal standards to control for RNA loading on the Northern blots
(see Materials and Methods) . (b) Mast cell reconstitution of one ear of
WIW° mice repairs the defect in IgE-dependent TNF-ot mRNA in the
mast cell-reconstituted ears, but not in the contralateral, mast cell-deficient
ears. (Left panel) Northern blot analysis of the TNF-a and actin mRNA
levels within reaction sites in mast cell-deficient (Defic.) ears and the con-
tralateral mast cell-reconstituted (Recon .) ears of W/Wv mice (N5 hg
of oligo-dT selected mRNA/lane) . (Right panel) Graphic presentation of
relativeTNF-amRNA levels in themast cell-deficient andmast cell-recon-
stituted reaction sites, as determined by laser densitometric analysis of the
Northern blot in left panel . As in a, the relative TNF-ot mRNA content
was corrected for variation in mRNA loading, by reference to the actin
signals.
cally treated sites in genetically mast cell-deficient W/W°
mice (Fig . 3 a, leftpane4 . When laser densitometry was used
to determine the ratios ofTNF-a and actinmRNA (relative
TNF-a mRNA content) in the ears, substantially more
TNF-a mRNA was present in the +/+ than in the mast
cell-deficient W/W" mouse ears (Fig . 3 a, right pane .
We then repeated the experiment, but in this case we in-
jected me IgE anti-DNP into the mast cell-deficient and con-
tralateral mast cell-reconstituted ears of W/W° mice, and
then challenged the animals with DNP-HSA 24 h later. In
accord with our previous study (17), extravasation of Evan's
blue dye indicated that PCA reactions developed in the mast
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cell-reconstituted but not in the contralateral mast cell-
deficient ears, and substantially more TNF-a mRNA was
present in the mast cell-reconstituted than in the mast
cell-deficient ears (Fig. 3 b) .
The present study shows that mast cell production ofTNF-
a/cachectin after IgE-dependent stimulation differs signifi-
cantly inboth mechanism and kinetics from the IgE-dependent
release ofsuch classical cytoplasmic granule-associated medi-
ators as 5-HT Several lines ofevidence, including the experi-
ments reported here, indicate that the release of 5-HT and
other preformed mediators reflects primarily the secretion of
product already stored in the cells' granules at the time of
cell activation (reviewed in references 1 and 2) . By contrast,
IgE-dependent stimulation ofthe mast cell induces both the
rapid release of preformed TNF-a, which is secreted with
a kinetics similar to that of 5-HT, as well as the synthesis
and secretion of large amounts of newly formed TNF-a .
These findings have several important implications. They
identify TNF-a/cachectin as the first of what arguably
represents anew class of mast cell-associated mediators : those
that are released with a prolonged kinetics reflecting the con-
tributions of both preformed and newly synthesized pools
ofproduct . These findings also identify a mechanismby which
the effects of mast cell-derived TNF-a can be sustained for
long periods of time during biological responses . Mast cells
have been proposed as a major source of the mediators that
regulate late phase reactions (LPRs), which in turn are re-
garded as a major cause of the tissue injury and morbidity
associated with asthma and other chronic, IgE-dependent dis-
orders (reviewed in references 1 and 19) . In addition to a myriad
of other biological actions (7, 8), TNF-a/cachectin can pro-
mote leukocyte recruitment through effects on both vascular
endothelial cells and leukocytes (reviewed in references 2, 20,
and 21) . The sustained release of TNF-ca by mast cells stimu-
lated via the FcERl thus represents a potential mechanism by
which mast cells can orchestrate leukocyte recruitment during
LPRs and other biological responses. In support of this hy-
pothesis, we showed that leukocyte recruitment during IgE-
dependent cutaneous LPRs in the mouse was virtually en-
tirely mast cell dependent, and that leukocyte infiltration into
these reactions was substantially reduced by injection of these
sites with antibodies to mouse recombinant TNF-a (22) .
Our findings may also have implications for the therapy
of diseases thought to involve mast cells. Conventional ther-
apeutic approaches to mast cell-associated disorders include
attempts to interfere with mast cell activation, with agents
such as sodium cromoglycate, or to antagonize the end organ
effects of mast cell mediators, with agents such as antihista-
mines or antagonists of lipid mediators (1, 2) . The finding
that substantial amounts of the TNF-ca produced by mouse
mast cells reflects product synthesized after the initial stimu-
lation of the cell, taken together with evidence that human
skin (23) and lung (24) mast cells represent potential sources
of TNF-a, suggests that agents that can interfere with the
synthesis ofTNF-a or other cytokines by mast cells may fa-
vorably affect the course of certain mast cell-associated dis-
orders (25) .We thankFu-TongLiuandDavidH. Katz forprovidingH1 DNP-e-26 hybridomacells, and Fred Finkelman
for providing rat me anti-mouse IgE.
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